mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.009 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.009 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |